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This study has been undertaken in order to elucidate the mechanisms of incorporation of Se into glutathione peroxidase 
(GSHPx), in which seleaocysteine corresponds to the opal termination codon UGA on the mRNA. We studied the above 
mechanisms using an opal suppressor tRNA, prepared from bovine liver, and caseia as a model protein for the GSHPx 
apo-enzyme which might contain phosphoserine. The results showed that opal suppressor tRNA did not accept seleao- 
cysteine (lower than 0.1 mmol/mol) under the standard conditions. A trace amount of phosphoseryl-tRNA was converted 
to selenocysteyl-tRNA by incubation with &Se and some enzymes. Meanwhile, a number of phosphoserine residues 
in casein were converted to seleaocysteiae r sidues by incubation with H,Se and enzymes. These results suggest hat opal 
suppressor tRNA plays a role in synthesizing GSHPx via co- and/or post-translational mechanisms. 
Suppressor tRNA; Glutathione peroxidase; Selenocysteine; Opal termination codon; Phosphoseryl-tRNA 
1. INTRODUCTION 
Glutathione peroxidase (GSHPx) plays an im- 
portant role in the detoxification of hydrogen 
peroxide, organic hydroperoxides and lipid perox- 
ides. Selenium is present in the form of selenocys- 
teine (SeCys) at the active site of this enzyme [ 1,2]. 
There are two possible mechanisms for incorpora- 
tion of SeCys at a precise location in the polypep- 
tide backbone of GSHPx. One is a co-translational 
pathway, in which a tRNA accepts SeCys by the 
specific SeCys-tRNA synthetase [3] and SeCys on 
the tRNA is incorporated into GSHPx by the nor- 
mal protein synthesis mechanism on ribosomes [4]. 
SeCys in formate dehydrogenase from Escherichia 
coli is inserted via a co-translational mechanism 
[5]. Another possibility is a post-translational 
mechanism, having been elucidated from results 
using perfused rat liver [6,7]. The results showed 
that the carbon source for the SeCys skeleton was 
provided by serine. The specific labeling of SeCys 
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with 14C from serine indicated that serine was the 
carbon source for SeCys. The specific activity is 
formed after incorporation of serine into GSHPx. 
Meanwhile, it is known that approx. 30% of the 
total bound Se in the body is found in GSHPx and 
that selenite is better than selenomethionine for in- 
corporation of Se into GSHPx. The in vivo syn- 
thesis of SeCys is not clear in mammals. 
The GSHPx gene has been sequenced and the 
codon for SeCys of the active site is UGA, the opal 
termination codon [8]. Meanwhile, there is only 
one tRNA species corresponding to UGA in mam- 
mals [9] and this tRNA accepts serine. This Ser- 
tRNA is phosphorylated by tRNA kinase [lo], the 
phosphoserine (Ps) on Ps-tRNA being incor- 
porated into phosphoprotein [ll]. In a previous 
report, we showed that suppressor tRNA has a 
150-fold weaker affinity for UGA than release fac- 
tor [ 121. Therefore, this suppressor tRNA does not 
play a suppressor role under normal conditions 
and the termination codon UGA is terminated by 
the release factor, except for some mRNAs which 
have a context structure near the UGA codon such 
as GSHPx mRNA. It has been discussed that this 
context effect arises from base pairing between a 
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5 ‘-flanking and a 3 ‘-flanking region near the 
codon UGA [7,13,14]. However, the general rule 
concerning this structure and the context effect has 
not been ascertained. 
In order to understand the role of mammalian 
opal suppressor tRNA which may be related to the 
incorporation of SeCys into GSHPx, we studied 
the three steps of protein synthesis relating to sup- 
pressor tRNA; the first is a search for tRNA which 
can accept SeCys, followed by conversion of Ps- 
tRNA to SeCys-tRNA, and finally conversion of 
Ps-protein to SeCys-protein. Here, H$Se, pro- 
duced from selenite and glutathione reductase, was 
used as the source of Se for incorporation into 
tRNA or proteins. 
2. EXPERIMENTAL 
Suppressor tRNA, SerRS and tRNA kinase were prepared 
from bovine liver according to [ 10,151. Crude enzyme prepara- 
tions for incorporation of Se were the supernatant (enzyme A) 
at 8000 x g of mouse liver homogenates, the supernatant at 
105000 x g (enzyme B), and the eluate at 0.3 M KC1 from 
DEAE-cellulose chromatography of the supernatant at 
105000 x g (enzyme C). HzSe, as Se source, was produced by 
a mixture of 10 PM selenite, 0.2 mM NADPH, 20 mM mercap- 
toethanol, 8 mM glutathione and 10 mM Hepes at pH 7.5 and 
5 fig/ml glutathione reductase from yeast (Boehringer) [16]. 
The phosphoprotein, used as a standard protein containing Ps, 
was milk casein. Alkaline phosphatase from calf intestine was 
a product of Boehringer. L-Selenocystine was a generous gift 
from Professor Kenji Soda of Kyoto University. Selenocysteine 
was produced from selenocystine by reduction in a mercap- 
toethanol solution. Carboxymethylation of proteins was per- 
formed with iodoacetic acid at neutral pH. Analysis of amino 
acids was performed through thin-layer chromatography on 
silica gel G with phenol/water (3: 1) and n-butanol/acetic 
acid/water (4: 1: 1). The amount of Se was determined by a 
fluorometric method using 2,3_diaminonaphthalene [17]. 
2.1. Pathway I (co-translational); tRNA’” + SeCys -+ 
SeCys-tRNA --+ GSHPx 
Suppressor tRNA (0.5 nmol) or crude bovine tRNA (10 mg) 
was incubated at 30°C for 30 min in a buffer (0.5 ml) compris- 
ing 0.2 M Hepes at pH 7.5,20 mM MgClz, 20 mM KC], 50 PM 
SeCys, 5 mM ATP, 10 mM mercaptoethanol and enzyme C 
(1.5 mg protein), in which SerRS and MetRS were active. The 
mixture was then chromatographed on Sephacryl S-200 (40 x 
1.3 cm) in 10 mM acetate buffer (pH 4.6) and 10 mM mercap- 
toethanol to separate Se-tRNA from free Se compounds. The 
amount of Se in the eluates from the column was assayed. 
2.2. Pathway 2Jco-iranslational); Ser-tRNA”” -+ 
Ps-tRNA - SeCys-tRNA - GSHPx 
The HzSe solution (0.1 ml) previously described was mixed 
with 0.1 ml Ps-tRNA solution, prepared by incubation for 
30 min at 30°C in a mixture containing suppressor tRNA 
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(0.5 nmol), SerRS, tRNA kinase, [‘%]Ser (170 Ci/mol) and 
ATP in buffer [lo]. Thereafter, 0.1 ml of 0.1 M Hepes (pH 6.4) 
was added to the HsSe-tRNA mixture in order to stabilize Ps- 
tRNA, and 30 ~1 enzyme B or C was added to the mixture. The 
solution was incubated for 30 min at 30°C. Subsequently, the 
tRNA solution was acidified by addition of 0.2 ml of 1 M 
acetate buffer (pH 4.6) and chromatographed on Sephacryl 
S-200 in 10 mM acetate (pH 4.6) and 10 mM mercaptoethanol. 
The peak of amino[‘4C]acyl-tRNA was collected by ethanol 
precipitation. The precipitate was washed with ethanol and 
dried. The tRNA was dissolved in 50 ,ul of 40 mM Tris base and 
10 mM mercaptoethanol, followed by incubation for 30 min at 
25°C to hydrolyze aminoacyl-tRNA to obtain free amino acids. 
r4C-labeled amino acids, liberated from amino[%]acyl-tRNA, 
were recovered in the supernatant by ethanol precipitation of 
tRNA and analyzed by TLC. Authentic unlabeled SeCys was 
developed on the same plate. Meanwhile, in order to determine 
the amount of Se on aminoacyl-tRNASU, unlabeled serine was 
used instead of [14C]serine under the same experimental con- 
ditions. 
2.3. Pathway 3 (post-translational); Ps-tRNA”’ - 
Ps-GSHPx (apo-envme) -+ SeCys-GSHPx (mature) 
Incorporation of Ps via Ps-tRNA into phosphoprotein was 
observed, however the yield of phosphoprotein was low as 
described in our previous report [l 11. Therefore, it is difficult 
to obtain sufficient amounts of Ps-GSHPx, in the above 
pathway, for analysis of the incorporation of Se into the apo- 
enzyme of GSHPx. We also do not have GSHPx mRNA at this 
stage. Thus, we continued the investigation by using milk casein 
as a model protein for Ps-dSHPx and studied the incorporation 
of Se into casein. 
Casein (20 mg) was dissolved in 0.5 ml HzSe solution. The 
reaction was initiated by the addition of 30 ~1 enzyme A or C, 
and then allowed to proceed for 2 or 24 h at 30°C. The mixture 
was chromatographed to remove free HzSe on a Sephacryl 
S-208 column in a solution composed of 0.1 M NaCI, 10 mM 
Tris-HCl (pH 7.5) and 10 mM mercaptoethanol. The amount 
of Se in the eluate from the column was determined. The casein 
fraction containing Se was dialyzed and lyophilized. Casein was 
dissolved in 5 mM mercaptoethanol and then reacted with 
30 mM iodoacetic acid. Subsequently, carboxymethyl(CM)- 
casein was hydrolyzed in 6 N HCI at 1OO’C for 2 h. This 
hydrolyzate was analyzed by TLC. Silica on the plate was 
scraped off and the amount of Se in the scrapings was analyzed. 
3. RESULTS 
The results concerning pathways l-3 are 
described sequentially. Fig.lA and B shows the 
chromatographic patterns on Sephacryl S-200 of 
crude and suppressor tRNAs incubated with en- 
zyme C in the presence of SeCys, respectively. The 
amount of SeCys binding to crude tRNA (fig.lA) 
and tRNASU (fig. 1B) was less than 0.1 mmol/mol 
tRNA, after subtraction of the basic amount of Se 
(1 ng/mg tRNA) in tRNA. Therefore, in pathway 
1, the results show that tRNA”” and crude tRNA 
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Fig.1. The chromatographic patterns of SeCys-tRNA on 
Sephacryl S-200 in 10 mM acetate buffer (pH 4.6) and 10 mM 
mercaptoethanol. (-) Absorbance at 260 nm; (0) amount 
of Se. (A) Crude tRNA; (B,C) suppressor tRNA; (B) tRNA 
incubated in the presence of SeCys, ATP and enzyme C; (C) Ps- 
tRNA incubated in the presence of HsSe and enzyme C. 
did not accept SeCys under the standard condi- 
tions. There remain two possible explanations for 
this lack of acceptance, namely that SeCys-tRNA 
synthetase is very labile, the other being that the 
amount of tRNA-specific SeCys present is very low 
in crude tRNA. Except for these two rare 
possibilities, the tRNA specific to SeCys is absent 
in mammals and suppressor tRNA does not accept 
SeCys. 
We show next the results on pathway 2 (Ps- 
tRNA + SeCys-tRNA). Fig.lC depicts Sepha- 
cry1 S-200 chromatography performed using the 
alcohol precipitate of the mixture of Ps-tRNA, 
HzSe solution and enzyme C. The Se peak did not 
overlap with that of tRNA but was found at the 
shoulder (tubes 31-33) of the peak. The amount of 
Se bound on tRNA was 2 mmol/mol tRNA. The 
suppressor tRNA bound a small amount of Se. In 
order to confirm the presence of SeCys on 
aminoacyl-tRNASU, [14C]Ps-tRNA was incubated 
in HzSe solution and isolated by chromatography 
on a Sephacryl S-200 column. The results of the 
analysis of r4C-labeled amino acids liberated from 
the amino[14C]acyl-tRNA are shown in frg.2. The 
radioactivity at the origin resulted from Ps. The 
major peak of Rf 0.20 was serine and the 14C- 
labeled amino acid of Rf 0.32 should be alanine. 
One minor peak of 14C was found at Rf 0.56. The 
percentage ratios of these amino acids were 8, 49, 
14 and 17%, respectively. The amino acid at Rf 
0.56 was not clear, however this position cor- 
responds to aliphatic amino acids in the solvent of 
phenol/water (3 : 1). Authentic SeCys migrated to 
Rf 0.50 but we could not observe any radioactivity 
at the position of SeCys in fig.2. However, when 
a greater amount of [3H]Ps-tRNA (some tens of 
thousands of cpm) was analyzed, a trace amount 
(0.1%) of total ‘H was clearly found at the posi- 
tion of authentic SeCys. Thus, we could not ex- 
clude the possibility of conversion of Ps-tRNA to 
SeCys-tRNA. 
The results with respect to pathway 3 
(phosphoprotein + SeCys-protein) were as 
follows. The chromatographic pattern for casein, 
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Fig.2. Analysis of “C-labeled amino acids liberated from 
aminoacyl-tRNA. r4C-labeled amino acids were prepared from 
suppressor tRNA which was incubated with [‘4C]serine, ATP, 
SerRS, tRNA kinase, HrSe and enzyme C. Analyses were 
performed on silica gel G with a solvent of phenol/water (3 : 1). 
Arrows l-4 denote positions of authentic Ps, Ser, Ala and 
SeCys, respectively. 
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incubated with H2Se solution and enzyme C, is 
shown in fig.3. Fig.3A depicts the pattern of the 
complete system. The fraction of the casein peak in 
the figure contained 22 ng Se/mg casein. This 
value remained unchanged after incubation for 
24 h. The amount of Se was found to be 
6 mmol/mol casein (casein contains 9 mol 
phosphoserine). From these results, it was con- 
cluded that none of the phosphoserine residues on 
casein were converted to SeCys, but restricted 
phosphoserine residues on one species in some ca- 
sein species hould be catalyzed. The structure near 
the special residues on casein might resemble that 
surrounding Ps on Ps-GSHPx. Fig.3B illustrates 
the result when enzyme C was omitted, fig.3C 
showing the case in which glutathione reductase 
was absent. Fig.3D shows the case for passage of 
the fraction through the DEAE-cellulose column, 
instead of enzyme C. Fig.3E shows the result with 
enzyme A. Thus, the enzyme converting Ps-protein 
was found in the crude fraction (enzyme A) and 
was partially purified to enzyme C by ultracen- 
trifugation and chromatography on DEAE- 
cellulose (activity bound on DEAE-cellulose). Fur- 
ther purification of this activity is planned for the 
TUBE NUMBER (Id/tube) 
Fig.3. Chromatographic pattern of Se-casein on Sephacryl 
S-200. (-) Absorbance at 280 nm; (0) amount of Se. (A) 
Complete; (B) enzyme C omitted; (C) glutathione reductase 
omitted; (D) protein passed through the DEAE-cellulose 
column instead of enzyme C; (E) enzyme A instead of enzyme 
C; (F) casein treated with phosphatase; (G) casein omitted; (H) 
albumin instead of casein in A. 
future. Fig.3F shows the result for casein treated 
with alkaline phosphatase. The casein peak in 
fig.3B-D,F contained no Se. These results in- 
dicated that enzyme C, glutathione reductase and 
Ps on casein were essential for production of Se- 
protein. Fig.3G shows the result for omission of 
casein, indicating that some enzymes in the reac- 
tion mixture, such as enzyme C and glutathione 
reductase, do not contain Se. Fig.3H shows the 
case for albumin instead of casein, albumin not 
undergoing the change to Se-albumin. Thus, we 
considered that the reaction with enzyme C was as 
follows: 
0- 
I 
R-O-P-O- + HzSe (or GSSeH) - 
II 
0 
0- 
I 
R-SeH + HO-P-O- (+ GS) 
II 
0 
In order to confirm the presence of SeCys in Se- 
casein, the main casein peak in fig.3A was 
modified with iodoacetic acid and hydrolyzed. The 
hydrolyzate was analyzed by TLC, giving the 
6 
4 
0 2 4 6 6 
DISTANCE (cm) 
Fig.4. Analysis of hydrolyzates of CM-casein containing Se on 
silica gel G with solvent A (phenol/water, 3: 1) and solvent B 
(n-butanol/acetic acid/water, 4: 1: 1). Arrows 1 and 2 indicate 
CM-SeCys and Ser, respectively. 
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Fig.5. Comparison of secondary structures of termination 
regions of some mRNAs. Termination codons are underlined. 
5 ’ - and 3 ‘-base-pairing regions are indicated by arrows. 
results shown in fig.4. CM-SeCys was found at a 
position identical with that of authentic CM-SeCys 
in both solvent systems. CM-SeCys amounted to 
approx. 20-30070 of total Se in the hydrolyzate. 
The results in fig.4 also show the presence of 
unidentified Se compounds in the hydrolyzate. It is 
not clear whether these unknown compounds were 
present in Se-casein or produced from SeCys dur- 
ing hydrolysis. Nevertheless, these results showed 
that Ps on phosphoprotein was converted to SeCys 
on the protein by some active enzymes. It is sug- 
gested that the phosphoprotein of GSHPx, in 
which Ps is incorporated at the position of the 
UGA codon through Ps-tRNA, is converted by 
some enzymes to mature GSHPx containing SeCys 
through a post-translational mechanism as are 
hydroxyproline and methyllysine [ 181. Finally, we 
drew the conclusion that natural opal suppressor 
tRNA plays an important role in synthesizing 
GSHPx. 
4. DISCUSSION 
In formate dehydrogenase mRNA, it was shown 
that the 3 ‘-flanking region of the UGA codon for 
SeCys could base-pair with the 5 ‘-flanking region, 
this base-pair giving rise to the context effect for 
suppressor tRNA to read the UGA termination 
codon [13]. Fig.5 shows some sequences of 
mRNAs near the termination codons. GSHPx and 
formate dehydrogenase have some base pairs be- 
tween the 5 ’ - and 3 ‘-flanking regions of the UGA 
codon. This base-pair has been found on mRNAs 
of human insulin and fl-globin but good matching 
has not been observed for human PTH and 
gastrin. Thus, this base-pair is one of the specific 
points of mRNA of GSHPx and formate 
dehydrogenase. Another specific base-pair was 
between GA of the UGA codon and UC of the 
5 ‘-flanking region of UGA on the mRNAs of 
GSHPx and formate dehydrogenase. This base- 
pair was not found on the other mRNAs shown in 
fig.5. By this pairing, the release factor cannot 
recognize UGA but a tRNA specific to UGA may 
attack the base-pair and interact with UGA. The 
base-pair between the 5 ’ - and 3 ‘-flanking bases of 
UGA may play a role in stabilizing the pairing be- 
tween GA of UGA and UC. Comparison between 
the regions near the UGA of mammals and of E. 
coli is interesting in that those regions near UGA, 
corresponding to SeCys, are able to compose the 
common structure of base-pairing. 
The results in fig.lA,B do not coincide with 
those of Hawkes and Tappel [3,4] who showed 
that one species of tRNACyS isoacceptors accepted 
SeCys. However, they did not demonstrate isola- 
tion of the tRNA specific to SeCys or SeCys-tRNA 
synthetase. In addition, they did not show that the 
tRNA containing Se corresponded to UGA or 
other codons. They found free SeCys in cytosol 
but the amount thereof was one half of that of 
SeCys-tRNA. Under normal conditions for protein 
synthesizing systems, amino acids are present at a 
concentration of about 20-50-fold that of the cor- 
responding tRNAs. Therefore, the amount of free 
SeCys given in the results of Hawkes and Tappel is 
low. We determined the concentration of SeCys in 
rabbit reticulocytes to be lower than 2 nM. This 
value is about 0.01% of that of other normal 
amino acids. It is difficult to conceive the SeCys- 
tRNA synthesizing system with such a low concen- 
tration of SeCys. The chromatographic pattern ob- 
tained for Se-tRNA by Hawkes and Tappel is 
similar to that of tRNA containing minor Se 
nucleotides [ 19,201. 
In fig.2, analyses of amino acids on aminoacyl- 
tRNA showed that part of the Ser-tRNA was con- 
verted to Ala-tRNA. This conversion proceeded in 
the presence of tRNASe’, SerRS and HzSe solution, 
over a short period of time. This reaction was also 
observed with tRNA$$ as the major isoacceptor. 
This result was very interesting, however we con- 
sidered that this reaction would proceed only in 
vitro, since, if this conversion proceeded in vivo, 
many unusual proteins, with Ala at the site of Ser, 
might be produced. Some organs possess SeCys 
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lyase which converts SeCys to Ala and HzSe [21]. 
The same result for production of Ala-tRNA was 
obtained with an extract from testes, in which 
SeCys lyase is present in low amounts. This result 
indicated that Ala-tRNA was not converted from 
SeCys-tRNA. The reaction from Ser-tRNA to Ala- 
tRNA may proceed through dehydro-Ala-tRNA. 
Ps is a high-energy compound [22], therefore 
conversion of Ps-tRNA or Ps-protein to SeCys- 
tRNA or SeCys-protein is easy. We were unable to 
conclude whether GSHPx was synthesized via a co- 
or post-translational mechanism. In the future, we 
shall attempt to clarify the mechanism using 
GSHPx mRNA and opal suppressor tRNA. We do 
not believe that the UGA codon changes to 
another codon after transcription, as in the case of 
apoB protein [23]. Other investigators have 
reported the absence of the GSHPx apo-enzyme in 
Se-deficient erythrocytes, using a monoclonal an- 
tibody specific to regions not relating to the active 
site of GSHPx [24]. They discussed the possibility 
that abnormal proteins such as an apo-enzyme 
may be unstable and, decompose. Meanwhile, the 
presence of the precursor (28 kDa) of GSHPx 
(21 kDa) in the in vitro protein synthesizing system 
using GSHPx mRNA has been reported [25]. The 
precursor might be the apo-enzyme of GSHPx 
containing Ps. It was also considered that the syn- 
thesis of apo-enzyme and suppressor serine tRNA 
was regulated by the presence of Se, as in the rela- 
tionship of metallothionein promoter and Zn. 
This study suggests that natural opal suppressor 
tRNA must concern the synthesis of GSHPx. 
However, other unknown suppressors may be pre- 
sent in the cytosol. One species of tRNATv cor- 
responds to UGA and some readthrough protein 
of &globin has been produced [26], but in the case 
of SeCys, it is difficult to conceive the exchange of 
indole with Se. Some problems remain to be 
resolved. We have examined the conversion of Ps- 
tRNA to SeCys-tRNA or Ps-protein to SeCys- 
protein using HzSe solution and some crude en- 
zymes. We have described here that H2Se in the 
solution might react with Ps-tRNA or casein, but 
the solution for producing HzSe contains other Se 
compounds such as glutathione selenopersulfide 
(GSSeH) which must attack Ps-tRNA or casein 
[16]. At present, the metabolism of organic Se 
compounds from Se02 in the human body has not 
been clarified even though SeCys is present in the 
active center of GSHPx. 
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